Germany
Japan
United Kingdom
China
ERK1 (MAPK3) rabbit polyclonal antibody, Aff - Purified
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
View as table Download
ERK1 (MAPK3) (+ERK2) rabbit polyclonal antibody, Aff - Purified
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
Rabbit Polyclonal Anti-Erk1/2 Antibody
| Applications | IF, WB |
| Reactivities | Chicken, Drosophila, Human, Mouse, Rat, Sheep, Xenopus, Cow |
| Conjugation | Unconjugated |
| Immunogen | A 35 residue synthetic peptide, corresponding to Erk1 MAP kinase with the CGG spacer group added and the peptide coupled to KLH. |
MAPK3 rabbit polyclonal antibody
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat, Fusion proteins containing the Flag Tag |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human MAPK3 |
ERK1/2 Rabbit polyclonal Antibody
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from human p44/42 MAPK. AA range:330-379 |
ERK1/2 Rabbit monoclonal Antibody
| Applications | IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- MAPK3
Applications
- IF
Antibody Hosts
- Rabbit
Filter by
Category
Reactivities
Isotypes
Clonalities
Conjugates
Pathways
- Acute myeloid leukemia (2)
- Adherens junction (2)
- Alzheimer's disease (2)
- Axon guidance (2)
- B cell receptor signaling pathway (2)
- Bladder cancer (2)
- Chemokine signaling pathway (2)
- Chronic myeloid leukemia (2)
- Colorectal cancer (2)
- Dorso-ventral axis formation (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Focal adhesion (2)
- Gap junction (2)
- Glioma (2)
- GnRH signaling pathway (2)
- Insulin signaling pathway (2)
- Long-term depression (2)
- Long-term potentiation (2)
- MAPK signaling pathway (2)
- Melanogenesis (2)
- Melanoma (2)
- NOD-like receptor signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Non-small cell lung cancer (2)
- Oocyte meiosis (2)
- Pancreatic cancer (2)
- Pathways in cancer (2)
- Prion diseases (2)
- Progesterone-mediated oocyte maturation (2)
- Prostate cancer (2)
- Regulation of actin cytoskeleton (2)
- Renal cell carcinoma (2)
- T cell receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Thyroid cancer (2)
- Toll-like receptor signaling pathway (2)
- Type II diabetes mellitus (2)
- VEGF signaling pathway (2)
- Vascular smooth muscle contraction (2)
- mTOR signaling pathway (2)